Mount Yale Investment Advisors, LLC Madrigal Pharmaceuticals, Inc. Transaction History
Mount Yale Investment Advisors, LLC
- $1.21 Billion
- Q2 2025
A detailed history of Mount Yale Investment Advisors, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Mount Yale Investment Advisors, LLC holds 311 shares of MDGL stock, worth $132,958. This represents 0.01% of its overall portfolio holdings.
Number of Shares
311Holding current value
$132,958% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding MDGL
# of Institutions
362Shares Held
23.3MCall Options Held
738KPut Options Held
473K-
Janus Henderson Group PLC London, X02.19MShares$937 Million0.34% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.09MShares$893 Million32.86% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$852 Million9.27% of portfolio
-
Baker Bros. Advisors LP New York, NY1.98MShares$845 Million6.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$803 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $7.31B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...